Get access to Glenmark information and resources for stories in development.
Find recent and archived press releases.
Glenmark Pharmaceuticals receives ANDA approval for Indomethacin Extended-Release Capsules USP, 75 mg
June 27, 2017
June 22, 2017
Glenmark Pharmaceuticals receives tentative ANDA approval for Solifenacin Succinate Tablets, 5 mg and 10 mg
June 21, 2017
Glenmark Pharmaceuticals Licenses Small Molecule Oncology Compound from APC Therapeutics to Expand Immuno-Oncology Portfolio
June 20, 2017
Search Result :-Is an investigational new drug that has not been approved for commercial distribution in the United States.
US Media Contact
For media inquiries only, please contact An Phan, Corporate Communications.
For more information on Glenmark Pharmaceuticals Ltd., including Annual Reports, Analyst Presentations and Financial Results, please visit our Investor Relations.